Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease

Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease

The program of renoprotection in patients with diabetes mellitus (DM) is based on a conceptual model of development and progressionof diabetic kidney disease, which is the result of combined impact of genetically modulated metabolic and hemodynamic factors. Compensationof carbohydrate metabolism, wh...

Full description

Saved in:

Bibliographic Details
Main Authors:	Minara Shamkhalovna Shamkhalova, Marina Vladimirovna Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2012-09-01
Series:	Сахарный диабет
Subjects:	diabetes mellitus chronic kidney disease diabetic nephropathy incretin-based therapy
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6087
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

All-Russia congress ?Diabetes and kidneys?, 17-19 may 2009, Moscow
by: Minara Shamkhalovna Shamkhalova
Published: (2009-06-01)

Diabetes mellitus and chronic kidney disease: achievements, unresolved problems, and prospects for therapy
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-03-01)

Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2013-09-01)

Features of pregnancy after simultaneous pancreas-kidney transplantation in patient with type 1 diabetes mellitus. Case report
by: Madina I. Yevloyeva, et al.
Published: (2024-12-01)

Prevalence of anemia in patients with type 1 and type 2 diabetes mellitus with chronic renal disease
by: Sergey A. Martynov, et al.
Published: (2017-12-01)

Factors of tubulointerstitial lesions in diabetic kidneys
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2009-12-01)

Obesity - a risk factor of renal pathology in patients with type 2 diabetes mellitus
by: Svetlana Alekseevna Savel'eva, et al.
Published: (2010-06-01)

Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016)
by: Minara S. Shamkhalova, et al.
Published: (2018-08-01)

A simultaneous pancreas-kidney transplantation for type 1 diabetes mellitus after a long-term of receiving hemodialysis renal replacement therapy. Clinical сase
by: R. Kh. Salimkhanov, et al.
Published: (2022-05-01)

New indications for exenatide therapy of type 2 diabetes mellitus
by: Olga Konstantinovna Vikulova, et al.
Published: (2010-09-01)

Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018-11-01)

World Kidney Day, 11 March 2010, devoted to the problem of renal pathology in diabetes mellitus
by: Sergey Andreevich Martynov
Published: (2010-03-01)

Early outcomes of kidney transplantation in recipients with type 1 diabetes mellitus and end‑stage kidney disease resulting from diabetic nephropathy
by: K. E. Lazareva, et al.
Published: (2025-01-01)

Trends in the epidemiology of chronic kidney disease in patients with diabetes in Russian Federation according to the Federal diabetes register (2010–2022)
by: M. S. Shamkhalova, et al.
Published: (2023-11-01)

Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease
by: T. Yu. Demidova, et al.
Published: (2021-05-01)

Cardiorenal relationships in patients with type 2 diabetes mellitus: new data of the ADVANCE study
by: Marina Vladimirovna Shestakova
Published: (2009-06-01)

Compromised calcium and phosphorus metabolism in patients with diabetes mellitus and chronic kidney disease
by: Margarita Stanislavovna Biragova, et al.
Published: (2012-12-01)

Simultaneous pancreas-kidney transplantation: Pro et Contra
by: Alexandra Mikhailovna Glazunova, et al.
Published: (2011-12-01)

Prevalence and Factors Predicting Nondiabetic Kidney Disease in Type 2 Diabetic Patients
by: Vignesh Subramani, et al.
Published: (2024-04-01)

Effect of statins and antihyperglycemics on chronic kidney disease in patients with type 2 diabetes mellitus: a retrospective cohort study with a 12-year follow-up
by: Ammar Abdulrahman Jairoun, et al.
Published: (2025-12-01)

Morphological changes of the kidneys according to autopsy data of persons with type 2 diabetes mellitus and arterial hypertension
by: V. G. Chobitko, et al.
Published: (2021-06-01)

Сytokines as promising diagnostic and prognostic biomarkers of microvascular complications of diabetes
by: V. V. Klimontov, et al.
Published: (2024-04-01)

Is it possible to achieve a safe glycated hemoglobin level during intensive hypoglycemic therapy? (results of ADVANCE study)
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-06-01)

Cardiorenal syndrome in patients with chronic kidney disease and diabetes mellitus
by: Irina Mikhailovna Kutyrina, et al.
Published: (2013-09-01)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, volume III
by: Maria Margherita Rando, et al.
Published: (2025-03-01)

Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective
by: Jorge Rico-Fontalvo, et al.
Published: (2024-11-01)

Modern methods of diagnosing chronic kidney disease in patients with diabetes mellitus
by: Tatiana N. Markova, et al.
Published: (2017-12-01)

THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS: RISKS AND PROSPECTS
by: L. Yu. Morgunov
Published: (2017-12-01)

Сhronic kidney disease complications in patients with type 1 diabetes mellitus after simultaneous pancreas-kidney transplantation – potential role of oxidative stress and glycation end products
by: Irina I. Larina, et al.
Published: (2019-12-01)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination
by: Anna Viktorovna Zheleznyakova, et al.
Published: (2014-10-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)

Clinically Indicated Renal Biopsy in Type 2 Diabetes Mellitus – It Is Not Always Nondiabetic Kidney Disease
by: Ramprasath Rajan, et al.
Published: (2024-10-01)

Measuring the Prevalence of Chronic Kidney Disease among Type 2 Diabetes Mellitus Patient in Hospital Jitra: A Population-Based Cohort Study
by: Norazila Abdul Ghani, et al.
Published: (2025-01-01)

The effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials
by: Ika Rahayu, et al.
Published: (2024-06-01)

Glycemic Variability in Different Stages of Chronic Kidney Disease with Type 2 Diabetes Mellitus: A Cross-sectional Study
by: Sapna Gupta, et al.
Published: (2024-04-01)

Evaluation of the effectiveness of diabetic nephropathy stage III in patients with type 2 diabetes mellitus therapy with sulodexide
by: V. G. Kadzharyan, et al.
Published: (2013-08-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Renal allograft nephropathy in patient with type 1 diabetes mellitus
by: Ekaterina Vladimirovna Ivannikova, et al.
Published: (2012-03-01)

Glucagon and alpha-cells as a novel therapeutic target in the management of diabetes mellitus
by: Nina Alexandrovna Petunina, et al.
Published: (2013-09-01)